New metformin-glibenclamide combination tablet may provide type 2 diabetics improved glycemic control than higher doses of either drug alone.

This simple intervention may prevent many cardiovascular events and deaths.

Results defer between repaglinide, glipizide and glibendamide

Babies that are longer and weigh more at birth may have a lower risk of developing type 2 diabetes.

Further evidence to suggest that almonds could benefit our health hit the press this week as scientists in Canada report that almonds significantly lowered bad cholesterol levels in a study of people with high cholesterol.

Research has shown cardiovascular disease is a major cause of death in patients with type 1 diabetes.

Initially thought that MSI-1436 could be an effective treatment for HIV because it stopped the reproduction of the virus in the lab. But found it had a greater potential for an obesity treatment.

Formal patient education programs often fail because of low levels of motivation and compliance from the patient or reluctance from the physicians to respond to information provided by patients.

Increasing body mass index (BMI) is associated with increasing risk for heart failure that, from an analysis of data from the Framingham Heart study.

Oral acarbose may be as effective as insulin therapy for glycemic control in patients with gestational diabetes if they adhere to dietary recommendations, a preliminary study of 110 patients suggests.